These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33000397)

  • 1. Long-Term Outcomes and Improvements in Quality of Life in Patients with Atrial Fibrillation Treated with Catheter Ablation vs. Antiarrhythmic Drugs.
    Zheng ZH; Fan J; Ji CC; Cheng YJ; Chen XM; Jiang JZ; Wu SH
    Am J Cardiovasc Drugs; 2021 May; 21(3):299-320. PubMed ID: 33000397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation vs. antiarrhythmic drugs as 'first-line' initial therapy for atrial fibrillation: a pooled analysis of randomized data.
    Chen S; Pürerfellner H; Ouyang F; Kiuchi MG; Meyer C; Martinek M; Futyma P; Zhu L; Schratter A; Wang J; Acou WJ; Ling Z; Yin Y; Liu S; Sommer P; Schmidt B; Chun JKR
    Europace; 2021 Dec; 23(12):1950-1960. PubMed ID: 34405878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation: A Meta-analysis of Randomized Controlled Trials.
    Xu B; Peng F; Tang W; Du Y; Guo H
    Ann Pharmacother; 2016 Sep; 50(9):697-705. PubMed ID: 27317015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.
    Turagam MK; Musikantow D; Whang W; Koruth JS; Miller MA; Langan MN; Sofi A; Choudry S; Dukkipati SR; Reddy VY
    JAMA Cardiol; 2021 Jun; 6(6):697-705. PubMed ID: 33909022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation-A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials.
    Chen W; Liu H; Ling Z; Xu Y; Fan J; Du H; Xiao P; Su L; Liu Z; Lan X; Zrenner B; Yin Y
    PLoS One; 2016; 11(5):e0156121. PubMed ID: 27224469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian network meta-analysis comparing cryoablation, radiofrequency ablation, and antiarrhythmic drugs as initial therapies for atrial fibrillation.
    Elsayed M; Abdelfattah OM; Sayed A; Prasad RM; Barakat AF; Elgendy IY; Andrade J; Jared Bunch T; Thosani A; Saliba WI; Wazni OM; Hussein AA
    J Cardiovasc Electrophysiol; 2022 Feb; 33(2):197-208. PubMed ID: 34855270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation.
    Rodgers M; McKenna C; Palmer S; Chambers D; Van Hout S; Golder S; Pepper C; Todd D; Woolacott N
    Health Technol Assess; 2008 Nov; 12(34):iii-iv, xi-xiii, 1-198. PubMed ID: 19036232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation for paroxysmal and persistent atrial fibrillation.
    Chen HS; Wen JM; Wu SN; Liu JP
    Cochrane Database Syst Rev; 2012 Apr; 2012(4):CD007101. PubMed ID: 22513945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of antiarrhythmic drugs to maintain sinus rhythm after catheter ablation for atrial fibrillation: a meta-analysis.
    Xu X; Alida CT; Yu B
    Cardiovasc Ther; 2015 Aug; 33(4):242-6. PubMed ID: 26031448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials.
    Dagres N; Varounis C; Flevari P; Piorkowski C; Bode K; Rallidis LS; Tsougos E; Leftheriotis D; Sommer P; Hindricks G; Kremastinos DT
    Am Heart J; 2009 Jul; 158(1):15-20. PubMed ID: 19540387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of catheter ablation versus antiarrhythmic drugs on atrial fibrillation: A meta-analysis of randomized controlled trials.
    Shi LZ; Heng R; Liu SM; Leng FY
    Exp Ther Med; 2015 Aug; 10(2):816-822. PubMed ID: 26622399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal rhythm-control strategy for recurrent atrial tachycardia after catheter ablation of persistent atrial fibrillation: a randomized clinical trial.
    Zhang XD; Gu J; Jiang WF; Zhao L; Zhou L; Wang YL; Liu YG; Liu X
    Eur Heart J; 2014 May; 35(20):1327-34. PubMed ID: 24497338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical Trial.
    Packer DL; Mark DB; Robb RA; Monahan KH; Bahnson TD; Poole JE; Noseworthy PA; Rosenberg YD; Jeffries N; Mitchell LB; Flaker GC; Pokushalov E; Romanov A; Bunch TJ; Noelker G; Ardashev A; Revishvili A; Wilber DJ; Cappato R; Kuck KH; Hindricks G; Davies DW; Kowey PR; Naccarelli GV; Reiffel JA; Piccini JP; Silverstein AP; Al-Khalidi HR; Lee KL;
    JAMA; 2019 Apr; 321(13):1261-1274. PubMed ID: 30874766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.
    Wokhlu A; Monahan KH; Hodge DO; Asirvatham SJ; Friedman PA; Munger TM; Bradley DJ; Bluhm CM; Haroldson JM; Packer DL
    J Am Coll Cardiol; 2010 May; 55(21):2308-16. PubMed ID: 20488300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.
    Reynolds MR; Walczak J; White SA; Cohen DJ; Wilber DJ
    Circ Cardiovasc Qual Outcomes; 2010 Nov; 3(6):615-23. PubMed ID: 20940250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced electrophysiologic mapping systems: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(8):1-101. PubMed ID: 23074499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catheter ablation versus medical therapy for patients with persistent atrial fibrillation: a systematic review and meta-analysis of evidence from randomized controlled trials.
    Chen C; Zhou X; Zhu M; Chen S; Chen J; Cai H; Dai J; Xu X; Mao W
    J Interv Card Electrophysiol; 2018 Jun; 52(1):9-18. PubMed ID: 29549512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
    Blomström-Lundqvist C; Gizurarson S; Schwieler J; Jensen SM; Bergfeldt L; Kennebäck G; Rubulis A; Malmborg H; Raatikainen P; Lönnerholm S; Höglund N; Mörtsell D
    JAMA; 2019 Mar; 321(11):1059-1068. PubMed ID: 30874754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure: A Meta-analysis of Randomized Controlled Trials.
    Turagam MK; Garg J; Whang W; Sartori S; Koruth JS; Miller MA; Langan N; Sofi A; Gomes A; Choudry S; Dukkipati SR; Reddy VY
    Ann Intern Med; 2019 Jan; 170(1):41-50. PubMed ID: 30583296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catheter ablation versus antiarrhythmic drugs with risk factor modification for treatment of atrial fibrillation: a protocol of a randomised controlled trial (PRAGUE-25 trial).
    Osmancik P; Havránek Š; Bulková V; Chovančík J; Roubíček T; Heřman D; Čarná Z; Tuka V; Matoulek M; Fiala M; Jiravský O; Stregl-Hruskova S; Latiňák A; Kotryová J; Jarkovský J
    BMJ Open; 2022 Jun; 12(6):e056522. PubMed ID: 35705334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.